How is AVEVA building GSK's pharmaceutical factory of the future?
GlaxoSmithKline is building its "Factory of the Future" program on AVEVA System Platform, AVEVA Reports and AVEVA PI System. This combination automates traditional processes, standardizes best practices and accelerates technology transfer between sites. AVEVA Performance Intelligence drives the digital transformation of pharmaceutical production by measuring, visualizing and anticipating industrial performance. It is a benchmark model for modernizing manufacturing sites in the life sciences.
Why standardize and replicate best practices in a pharmaceutical plant?
GSK operates multiple production sites around the world. Standardization through AVEVA System Platform makes it possible to capture best practices at one site and quickly replicate them elsewhere, ensuring consistent quality and comparable efficiency. This harmonization is crucial in pharma, where regulatory compliance and product traceability determine marketing authorization. Standardization becomes a lever for scalability and overall robustness.
How can AVEVA speed up time-to-market for new medicines?
AVEVA improves technology transfer at GSK by digitizing recipes, processes and validation documentation. Moving a medicine from the laboratory to industrial production is thus accelerated: process parameters are faithfully reproduced, deviations are detected quickly and the ramp-up is secured. In a sector where every month gained on time-to-market represents hundreds of millions in revenue, this acceleration is strategic.
What role does AVEVA PI System play in advanced pharmaceutical manufacturing?
At GSK, AVEVA PI System is the high-performance industrial historization infrastructure that collects the critical parameters of pharmaceutical processes. Combined with System Platform and Reports, it feeds predictive analytics, regulatory reporting and continuous improvement. This unified operational information management platform turns data into a source of supply chain optimization and growth in global business opportunities.
Why measure, visualize and anticipate industrial performance in pharma?
Industrial performance in pharma combines quality, compliance, cost and sustainability. At GSK, AVEVA Reports and Performance Intelligence turn operational data into real-time, actionable indicators. Measuring helps understanding, visualizing makes decisions easier and anticipating prevents deviations. This virtuous cycle powered by AVEVA improves the group's long-term performance and opens up new business opportunities in demanding global markets.
